Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Development and validation of the FrBio, an international French adaptation of the AzBio sentence lists.

Bergeron F, Berland A, Fitzpatrick EM, Vincent C, Giasson A, Leung Kam K, Chafiq W, Fanouillère T, Demers D.

Int J Audiol. 2019 Aug;58(8):510-515. doi: 10.1080/14992027.2019.1581950. Epub 2019 May 10.

PMID:
31074295
2.

Phosphorylation of GATA4 serine 105 but not serine 261 is required for testosterone production in the male mouse.

Bergeron F, Boulende Sab A, Bouchard MF, Taniguchi H, Souchkova O, Brousseau C, Tremblay JJ, Pilon N, Viger RS.

Andrology. 2019 May;7(3):357-372. doi: 10.1111/andr.12601. Epub 2019 Feb 22.

PMID:
30793514
3.

In Vivo Ablation of the Conserved GATA-Binding Motif in the Amh Promoter Impairs Amh Expression in the Male Mouse.

Bouchard MF, Bergeron F, Grenier Delaney J, Harvey LM, Viger RS.

Endocrinology. 2019 Apr 1;160(4):817-826. doi: 10.1210/en.2019-00047.

PMID:
30759208
4.

Golden ratio and phyllotaxis, a clear mathematical link.

Bergeron F, Reutenauer C.

J Math Biol. 2019 Jan;78(1-2):1-19. doi: 10.1007/s00285-018-1265-3. Epub 2018 Jul 23.

PMID:
30039356
5.

Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents.

Abdallah K, Nadeau F, Bergeron F, Blouin S, Blais V, Bradbury KM, Lavoie CL, Parent JL, Gendron L.

Sci Rep. 2018 May 9;8(1):7321. doi: 10.1038/s41598-018-25626-y.

6.

FOXA3 Is Expressed in Multiple Cell Lineages in the Mouse Testis and Regulates Pdgfra Expression in Leydig Cells.

Garon G, Bergeron F, Brousseau C, Robert NM, Tremblay JJ.

Endocrinology. 2017 Jun 1;158(6):1886-1897. doi: 10.1210/en.2016-1736.

PMID:
28379539
7.

Food avoidance in patients with inflammatory bowel disease: What, when and who?

Bergeron F, Bouin M, D'Aoust L, Lemoyne M, Presse N.

Clin Nutr. 2018 Jun;37(3):884-889. doi: 10.1016/j.clnu.2017.03.010. Epub 2017 Mar 15.

PMID:
28359542
8.

Early CT changes in patients admitted for thrombectomy: Intrarater and interrater agreement.

Farzin B, Fahed R, Guilbert F, Poppe AY, Daneault N, Durocher AP, Lanthier S, Boudjani H, Khoury NN, Roy D, Weill A, Gentric JC, Batista AL, Létourneau-Guillon L, Bergeron F, Henry MA, Darsaut TE, Raymond J.

Neurology. 2016 Jul 19;87(3):249-56. doi: 10.1212/WNL.0000000000002860. Epub 2016 Jun 17. Review.

9.

Perception in noise with the Digisonic SP cochlear implant: Clinical trial of Saphyr processor's upgraded signal processing.

Bergeron F, Hotton M.

Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Jun;133 Suppl 1:S4-6. doi: 10.1016/j.anorl.2016.04.019. Epub 2016 May 27.

11.

[Victimization, mental health and well-being among trans youths in the province of Quebec].

Raymond G, Blais M, Bergeron FA, Hébert M.

Sante Ment Que. Fall 2015;40(3):77-92. French.

12.

KLF6 cooperates with NUR77 and SF1 to activate the human INSL3 promoter in mouse MA-10 leydig cells.

Tremblay MA, Mendoza-Villarroel RE, Robert NM, Bergeron F, Tremblay JJ.

J Mol Endocrinol. 2016 Apr;56(3):163-73. doi: 10.1530/JME-15-0139. Epub 2016 Feb 12.

PMID:
26874000
13.

The Transcription Factor MEF2 Is a Novel Regulator of Gsta Gene Class in Mouse MA-10 Leydig Cells.

Di-Luoffo M, Brousseau C, Bergeron F, Tremblay JJ.

Endocrinology. 2015 Dec;156(12):4695-706. doi: 10.1210/en.2015-1500. Epub 2015 Sep 22.

PMID:
26393304
14.

Health Outcomes of Sexual-Minority Youth in Canada: An Overview.

Blais M, Bergeron FA, Duford J, Boislard MA, Hébert M.

Adolesc Saude. 2015 Jul 1;12(3):53-73.

15.

Novel Targets for the Transcription Factors MEF2 in MA-10 Leydig Cells.

Di-Luoffo M, Daems C, Bergeron F, Tremblay JJ.

Biol Reprod. 2015 Jul;93(1):9. doi: 10.1095/biolreprod.114.127761. Epub 2015 May 27.

16.

A Retrospective Multicenter Study Comparing Speech Perception Outcomes for Bilateral Implantation and Bimodal Rehabilitation.

Blamey PJ, Maat B, Başkent D, Mawman D, Burke E, Dillier N, Beynon A, Kleine-Punte A, Govaerts PJ, Skarzynski PH, Huber AM, Sterkers-Artières F, Van de Heyning P, O'Leary S, Fraysse B, Green K, Sterkers O, Venail F, Skarzynski H, Vincent C, Truy E, Dowell R, Bergeron F, Lazard DS.

Ear Hear. 2015 Jul-Aug;36(4):408-16. doi: 10.1097/AUD.0000000000000150.

17.

GATA4 knockdown in MA-10 Leydig cells identifies multiple target genes in the steroidogenic pathway.

Bergeron F, Nadeau G, Viger RS.

Reproduction. 2015 Mar;149(3):245-57. doi: 10.1530/REP-14-0369. Epub 2014 Dec 12.

PMID:
25504870
18.

A cell-autonomous molecular cascade initiated by AMP-activated protein kinase represses steroidogenesis.

Abdou HS, Bergeron F, Tremblay JJ.

Mol Cell Biol. 2014 Dec 1;34(23):4257-71. doi: 10.1128/MCB.00734-14. Epub 2014 Sep 15.

19.

Comparison of eSRTs and comfort levels in users of Digisonic SP cochlear implants.

Bergeron F, Hotton M.

Cochlear Implants Int. 2015 Mar;16(2):110-4. doi: 10.1179/1754762814Y.0000000092. Epub 2014 Aug 12.

PMID:
25117973
20.

GATA4 autoregulates its own expression in mouse gonadal cells via its distal 1b promoter.

Mazaud-Guittot S, Prud'homme B, Bouchard MF, Bergeron F, Daems C, Tevosian SG, Viger RS.

Biol Reprod. 2014 Feb 6;90(2):25. doi: 10.1095/biolreprod.113.113290. Print 2014 Feb.

PMID:
24352556
21.

Photonic bandgap Bragg fiber sensors for bending/displacement detection.

Qu H, Brastaviceanu T, Bergeron F, Olesik J, Pavlov I, Ishigure T, Skorobogatiy M.

Appl Opt. 2013 Sep 1;52(25):6344-9. doi: 10.1364/AO.52.006344.

PMID:
24085096
22.

CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF.

Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, Panzini B, Soucy G, Wassef R, Richard C, Tamaz R, Lahaie R, Bernard EJ, Caussignac Y, Leduc R, Lougnarath R, Bergeron C, Racicot MA, Bergeron F, Panzini MA, Demetter P, Franchimont D, Schäkel K, Weckbecker G, Kolbinger F, Heusser C, Huber T, Welzenbach K, Sarfati M.

J Exp Med. 2013 Jun 3;210(6):1251-63. doi: 10.1084/jem.20122037. Epub 2013 May 13.

23.

Pre-, per- and postoperative factors affecting performance of postlinguistically deaf adults using cochlear implants: a new conceptual model over time.

Lazard DS, Vincent C, Venail F, Van de Heyning P, Truy E, Sterkers O, Skarzynski PH, Skarzynski H, Schauwers K, O'Leary S, Mawman D, Maat B, Kleine-Punte A, Huber AM, Green K, Govaerts PJ, Fraysse B, Dowell R, Dillier N, Burke E, Beynon A, Bergeron F, Başkent D, Artières F, Blamey PJ.

PLoS One. 2012;7(11):e48739. doi: 10.1371/journal.pone.0048739. Epub 2012 Nov 9.

24.

Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants: an update with 2251 patients.

Blamey P, Artieres F, Başkent D, Bergeron F, Beynon A, Burke E, Dillier N, Dowell R, Fraysse B, Gallégo S, Govaerts PJ, Green K, Huber AM, Kleine-Punte A, Maat B, Marx M, Mawman D, Mosnier I, O'Connor AF, O'Leary S, Rousset A, Schauwers K, Skarzynski H, Skarzynski PH, Sterkers O, Terranti A, Truy E, Van de Heyning P, Venail F, Vincent C, Lazard DS.

Audiol Neurootol. 2013;18(1):36-47. doi: 10.1159/000343189. Epub 2012 Oct 19.

25.

Functional cooperation between GATA factors and cJUN on the star promoter in MA-10 Leydig cells.

Martin LJ, Bergeron F, Viger RS, Tremblay JJ.

J Androl. 2012 Jan-Feb;33(1):81-7. doi: 10.2164/jandrol.110.012039. Epub 2011 Feb 24.

PMID:
21350237
26.

Transcription of platelet-derived growth factor receptor α in Leydig cells involves specificity protein 1 and 3.

Bergeron F, Bagu ET, Tremblay JJ.

J Mol Endocrinol. 2011 Mar 23;46(2):125-38. doi: 10.1530/JME-10-0145. Print 2011 Apr.

PMID:
21289081
27.

Message transmission efficiency through five telecommunication technologies for signing deaf users.

Vincent C, Bergeron F, Hotton M, Deaudelin I.

Assist Technol. 2010 Fall;22(3):141-51.

PMID:
20939423
28.

HO* radicals induce an unexpected high proportion of tandem base lesions refractory to repair by DNA glycosylases.

Bergeron F, Auvré F, Radicella JP, Ravanat JL.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5528-33. doi: 10.1073/pnas.1000193107. Epub 2010 Mar 8.

29.

Cochlear implantation in postmeningitic deafness.

Philippon D, Bergeron F, Ferron P, Bussières R.

Otol Neurotol. 2010 Jan;31(1):83-7.

PMID:
20050267
30.

Language achievement in children who received cochlear implants between 1 and 2 years of age: group trends and individual patterns.

Duchesne L, Sutton A, Bergeron F.

J Deaf Stud Deaf Educ. 2009 Fall;14(4):465-85. doi: 10.1093/deafed/enp010. Epub 2009 May 21.

PMID:
19461113
31.

Reaching for the other side: generating sequence-dependent interstrand cross-links with 5-bromodeoxyuridine and gamma-rays.

Dextraze ME, Cecchini S, Bergeron F, Girouard S, Turcotte K, Wagner JR, Hunting DJ.

Biochemistry. 2009 Mar 10;48(9):2005-11. doi: 10.1021/bi801684t.

PMID:
19216505
32.

Over-the-fence cochlear implantation: is it worthwhile?

Tremblay G, Bergeron F, Ferron P.

J Otolaryngol Head Neck Surg. 2008 Jun;37(3):440-5.

PMID:
19128652
33.

The nuclear receptors SF1 and LRH1 are expressed in endometrial cancer cells and regulate steroidogenic gene transcription by cooperating with AP-1 factors.

Dubé C, Bergeron F, Vaillant MJ, Robert NM, Brousseau C, Tremblay JJ.

Cancer Lett. 2009 Mar 8;275(1):127-38. doi: 10.1016/j.canlet.2008.10.008. Epub 2008 Nov 20.

PMID:
19022561
34.

Utility of ear implants: can all benefits be valued?

Bergeron F, Ferron P.

Cochlear Implants Int. 2005 Sep;6 Suppl 1:2-3. doi: 10.1179/cim.2005.6.Supplement-1.2. No abstract available.

PMID:
18792340
35.

Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.

Ofner-Agostini M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson E, Stegenga J, Bergeron F; Canadian Nosocomial Infection Surveillance Program, Gravel D.

Am J Infect Control. 2007 Nov;35(9):563-8.

PMID:
17980232
36.

Cochlear reimplantation: causes of failure, outcomes, and audiologic performance.

Côté M, Ferron P, Bergeron F, Bussières R.

Laryngoscope. 2007 Jul;117(7):1225-35.

PMID:
17603321
37.

Mechanical loading modulates the differentiation state of vascular smooth muscle cells.

Grenier G, Rémy-Zolghadri M, Bergeron F, Guignard R, Baker K, Labbé R, Auger FA, Germain L.

Tissue Eng. 2006 Nov;12(11):3159-70.

PMID:
17518630
38.

Lineage-specific transcription factors in multipotent hematopoietic progenitors: a little bit goes a long way.

Bottardi S, Ghiam AF, Bergeron F, Milot E.

Cell Cycle. 2007 May 2;6(9):1035-9. Epub 2007 May 29. Review.

PMID:
17457053
39.
40.

Near-UV induced interstrand cross-links in anthraquinone-DNA duplexes.

Bergeron F, Nair VK, Wagner JR.

J Am Chem Soc. 2006 Nov 22;128(46):14798-9.

PMID:
17105277
41.

Cross-modal reorganization and speech perception in cochlear implant users.

Doucet ME, Bergeron F, Lassonde M, Ferron P, Lepore F.

Brain. 2006 Dec;129(Pt 12):3376-83. Epub 2006 Sep 26.

PMID:
17003067
42.

Tissue reorganization in response to mechanical load increases functionality.

Grenier G, Rémy-Zolghadri M, Larouche D, Gauvin R, Baker K, Bergeron F, Dupuis D, Langelier E, Rancourt D, Auger FA, Germain L.

Tissue Eng. 2005 Jan-Feb;11(1-2):90-100.

PMID:
15738664
43.

Electron transfer in DNA duplexes containing 2-methyl-1,4-naphthoquinone.

Bergeron F, Houde D, Hunting DJ, Wagner JR.

Nucleic Acids Res. 2004 Dec 7;32(21):6154-263. Print 2004.

44.

Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity.

Kasibhatla S, Gourdeau H, Meerovitch K, Drewe J, Reddy S, Qiu L, Zhang H, Bergeron F, Bouffard D, Yang Q, Herich J, Lamothe S, Cai SX, Tseng B.

Mol Cancer Ther. 2004 Nov;3(11):1365-74.

45.

Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B.

Fontés G, Lajoix AD, Bergeron F, Cadel S, Prat A, Foulon T, Gross R, Dalle S, Le-Nguyen D, Tribillac F, Bataille D.

Endocrinology. 2005 Feb;146(2):702-12. Epub 2004 Nov 11.

PMID:
15539558
46.

Oxidation of 5-hydroxy-2'-deoxyuridine into isodialuric acid, dialuric acid, and hydantoin products.

Rivière J, Bergeron F, Tremblay S, Gasparutto D, Cadet J, Wagner JR.

J Am Chem Soc. 2004 Jun 2;126(21):6548-9.

PMID:
15161271
47.

Isolation and culture of the three vascular cell types from a small vein biopsy sample.

Grenier G, Remy-Zolghadri M, Guignard R, Bergeron F, Labbe R, Auger FA, Germain L.

In Vitro Cell Dev Biol Anim. 2003 Mar-Apr;39(3-4):131-9.

PMID:
14505434
48.

A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.

Meerovitch K, Bergeron F, Leblond L, Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T, Attardo G.

Vascul Pharmacol. 2003 Feb;40(2):77-89.

PMID:
12646396
49.

Thiophene-based vitronectin receptor antagonists.

Bubenik M, Meerovitch K, Bergeron F, Attardo G, Chan L.

Bioorg Med Chem Lett. 2003 Feb 10;13(3):503-6.

PMID:
12565960
50.

Residual hearing following a cochlear implantation: effect of time and device.

Bergeron F.

Adv Otorhinolaryngol. 2000;57:389-92. No abstract available.

PMID:
11892197

Supplemental Content

Loading ...
Support Center